Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer By Ogkologos - April 16, 2026 80 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a phase III study in patients recruited through the PATCH and STAMPEDE-1 trial networks Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Two Separate Indications for fam-Trastuzumab Deruxtecan-nxki in HER2-Positive Early-Stage Breast Cancer ESMO Calls for Further EU Measures Enhancing Europe’s Clinical Trial Regulatory Ecosystem Following Meeting of Health Ministers on 16 June 2026 ESMO Responds to Public Consultation on EU4Health Work Programme for 2027 and Highlights the Importance of Continuing Robust EU Support for Europe’s Beating Cancer... MOST POPULAR Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin Lymphoma November 14, 2024 Câncer em minha comunidade: Trabalhando para expandir o acesso a estudos... September 22, 2022 We’re asking scientists to tackle 9 of the toughest challenges in... October 14, 2020 Piecing together the puzzle: Antibiotics, the microbiome and bowel cancer March 15, 2022 Load more HOT NEWS FDA Approves Tremelimumab in Combination with Durvalumab for Unresectable Hepatocellular Carcinoma Caregivers Empower the Next Generation of Cancer Care Though the Pandemic Has Slowed, Many Are Still Struggling to Put... 4 Ways to Avoid Comparing Yourself to Others on Social Media...
